Harkány, T., Lengyel, Z., Soós, K., Penke, B., Luiten, P.G., Gulya, K.:
Cholinotoxic effects of b-amyloid (1-42) peptide on cortical projections of the rat nucleus basalis magnocellularis
Brain Research 695, 71-75, 1995. IF = 2.119
i = 18
Laczkó, I., Vass, E., Soós, K., Varga, J. L., Szárzaz, S., Hollósi, M., Penke, B.,:
Ca2+ - and Al3+ induced conformational transitions of amyloid fragment H-IIe-IIe-Gly-Leu-Met-NH2
Arch. Biochemistry and Biophysics 335, 381-387 1996. IF = 2.649
i = 8
Laskay G., Zarándi M., Varga J., Jost K., Fónagy A., Torday C., Latzkovits L., Penke B.:
A putative tetrapeptide antagonist prevents b-amyloid-induced long-term elevation of [Ca2+]i
Biochem. Biophys. Res. Commun. 235, 479-481, 1997. IF = 2.671
i = 7
Jancsó G., Domoki F., Sántha P., Varga J., Fischer J., Orosz K., Penke B., Becskei A., Dux M., Tóth L.,: b-Amyloid (1-42) peptide impairs blood-brain barier function after intracarotid infusion in rats.
Neuroscience Letters 253, 139-141, 1998. IF = 1.768
i = 8
Pákáski M., Farkas Z., Kása P. Jr., Forgon M., Papp K., Zarándi M., Penke B., Kása P. Sr.:
Vulnerability of small GABAergic neurons to human b-amyloid pentapeptide.
Brain Research 796, 239-246, 1998. IF = 2.119
Harkány, T., Ábrahám, I., Laskay, G., Timmerman, W., Jost, K., Zarándi, M., Penke, B., Nyakas, C., Luiten, P.G.M. Propionyl-IIGL tetrapeptide antagonizes b-amyloid excitotoxicity in rat nucleus basalis.
Neuroreport 10, 1693-1698, 1999. IF = 2.262
Harkány, T., Ábrahám, I., Timmerman, W., Laskay, G., Tóth, B., Sasvári, M., Kónya, C., Sebens, JB., Korf, J., Nyakas, C., Zarándi, M., Soós, K., Penke, B., Luiten, PGM.: b-Amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis
Eur. J. Neurosci. 12, 2735-2745, 2000. IF = 3.899
Harkány, T., Ábrahám, I., Kónya, C., Zarándi, M., Penke, B., Luiten, P.G.M.:
Mechanism of b-amyloid neurotoxicity:perspectives of pharmacotherapy.
Rev. Neurosci. 11 , 329-382, 2000. IF = 3.387
Harkány, T, O’Mahony, S., Kelly, JP., Kónya, C., Keijser, JN., Borostyánkői, ZA., Görcs, T., Zarándi, M., Penke, B., Leonard, BE., Luiten, PGM.: b-Amyloid-induced cholinergic lesions to the rat nucleus basalis bi-directinally modulate serotonergic activity in basal forebrain and cerebral cortex.
Neurobiol Dis., 8 , 667-678 (2001) IF = 4.225
DeMager, P.P., Penke, B., Walter, R., Harkany, T., Härtig, W.: Pathological peptide folding in Alzheimer’s disease and other conformational disorders.
Current Medicinal Chemistry 9, 1763-1780, 2002. IF =4.909
Fassbender K., Walter S., Kühl S., Landmann R., Ishii K., Bertsch T., Stalder A.K., Muehlhauser F., Liu Y., Ulmer A.J., Rivest S., Lentschat A., Gulbins E., Jucker M., Stufenbiel M., Brechtel K., Walter J., Multhaup G., Penke B., Adachi Y., Hartmann T. and Beyreuther K.: The LPS receptor, CD14 links innate immunity with Alzheimer’s disease.
FASEB Journal , 17, U518-U532, 2003. IF = 7,252
Verdier Y., Zarándi M., Penke B.: Amyloid ß-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer’s disease.
J. Peptide Sci 10, 229-248, 2004. IF = 1.471
Verdier, Y. Penke, B.: Binding sites of amyloid-ß-peptide in cell plasma membrane and implications for Alzheimer’s disease.
Current Protein and Peptide Science 5 , 19-31, 2004 IF = 1,71
Szegedi V, Juhasz G, Rozsa E, Juhasz-Vedres G, Datki Z, Fulop L, Bozso Z, Lakatos A, Laczko I, Farkas T, Kis Z, Toth G, Soos K, Zarandi M, Budai D, Toldi J, Penke B.
Endomorphin-2, an endogenous tetrapeptide, protects against Abeta1-42 in vitro and in vivo.
FASEB J. 20(8), 1191-3., 2006
Zarándi M., Soós K., Fülöp L., Bozsó Zs, Datki Zs, Tóth G.K., Penke B.:
Synthesis of Aß(1-42) and its derivatives with improved efficiency
Peptide Sci., 2006, in press
